ORGANIZATION |
ACTIVITY |
DATES |
Equity Reference Group for Immunisation
|
Member
|
2023 – |
Gavi, the Vaccine Alliance
|
Chair, Steering Committee, Evaluation of Gavi’s contribution to reaching Zero-Dose children and missed communities
|
2022-2023 |
The Global Fund
|
Chair, Independent Evaluation Panel
|
2022-2024 |
IC-IMPACTS The India-Canada Centre for Innovative Multidisciplinary Partnerships to Accelerate Community Transformation and Sustainability
|
Member, Board of Directors and Chair, Committee for Equity, Diversity and Inclusion |
2022-2023 |
Coalition for Epidemic Preparedness Innovations (CEPI)
|
Chair, Evaluation Committee for the Independent outcome evaluation of CEPI 1.0
|
2022 |
Gavi, the Vaccine Alliance
|
Member, Steering Committee, COVAX Facility and COVAX Advance Market Commitment (AMC) Evaluability, Evaluation Design, and Baseline Study
|
2021 -2022 |
The Global Fund to Fight AIDS, Tuberculosis and Malaria
|
Chair, Steering Committee for the External evaluation of the Prospective Country Evaluations (PCE)
|
2021 |
Gavi, the Vaccine Alliance
|
Member, Evaluation Advisory Committee
|
2012 – 2017;
2018 – 2019;
2019 – 2021; 2021-2023 |
The Lancet |
Commissioner, Lancet Commission on Global Hearing Loss |
2019 – 2021 |
Raah Health and Social Development Foundation |
Chair of the Advisory Board |
2020 – |
World Health Organization; UNICEF |
Consultant, Global Consultation on Redesigning Child and Adolescent Health Programming to address Child Health Priorities in the context of the Sustainable Development Goals (SDGs) |
2019 |
CCGHR |
Member, Board of Directors, Canadian Coalition for Global Health Research |
2016 –2020 |
Yale University |
Member, Board of Directors, Association of Yale Alumni in Public Health (AYAPH) |
2017-2020 |
World Health Organization, Department of maternal, newborn, child and adolescent health (MCA) |
Temporary Advisor to WHO & Leader of the Child Health Working Group, Defining global research priorities: Social, behavioural and community engagement interventions for maternal, newborn and child health. |
2018 |
Gavi, the Vaccine Alliance |
Chair, Steering Committee, Evaluation of the Targeted Country Assistance (TCA) provided through the Gavi Partners’ Engagement Framework (PEF) |
2018 |
Gavi, the Vaccine Alliance |
Member, Adjudication committee: Final evaluation of GAVI Alliance support to China |
2012 |
Gavi, the Vaccine Alliance |
Member, Expert Advisory Panel on Defining GAVI’s Research Agenda |
2012 |
Gavi, the Vaccine Alliance |
Member, GAVI Alliance Prioritisation Mechanism Independent Review Committee |
2011 |
The Global Fund to fight HIV/AIDS, Tuberculosis and Malaria |
Member, Development of practical guidance to country implementing partners and Country Coordinating Mechanisms (CCMs) to promote health equity through Global Fund grants |
2011 |
World Health Organization, Cost-effectiveness and priority-setting (CEP) |
Member, Scientific & organising committee, Development of guidance for priority setting in health, Brocher Foundation, Geneva 2010 |
2011 |
World Health Organization, Cost-effectiveness and priority-setting (CEP) |
Member, Scientific & organising committee, Development of a checklist for priority setting, Chateau de Penthes, Geneva, Geneva 2010 |
2010 |
Gavi, the Vaccine Alliance |
Member, Evaluation of the International Financing Facility for Immunisation (IFFIm) |
2010 |